Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;204(3):497-507.
doi: 10.1007/s10549-023-07192-8. Epub 2024 Jan 8.

Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome

Annemiek van Hemert  1 , Ariane A van Loevezijn  1 , Anne Bosman  1   2 , Carmen A Vlahu  3 , Claudette E Loo  4 , Marie-Jeanne T F D Vrancken Peeters  1 , Frederieke H van Duijnhoven  1 , Iris M C van der Ploeg  5
Affiliations

Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome

Annemiek van Hemert et al. Breast Cancer Res Treat. 2024 Apr.

Abstract

Introduction: Breast cancer patients with invasive lobular carcinoma (ILC) have an increased risk of positive margins after surgery and often show little response to neoadjuvant chemotherapy (NAC). We aimed to investigate surgical outcomes in patients with ILC treated with NAC.

Methods: In this retrospective cohort study, all breast cancer patients with ILC treated with NAC who underwent surgery at the Netherlands Cancer Institute from 2010 to 2019 were selected. Patients with mixed type ILC in pre-NAC biopsies were excluded if the lobular component was not confirmed in the surgical specimen. Main outcomes were tumor-positive margins and re-excision rate. Associations between baseline characteristics and tumor-positive margins were assessed, as were complications, locoregional recurrence rate (LRR), recurrence-free survival (RFS), and overall survival (OS).

Results: We included 191 patients. After NAC, 107 (56%) patients had breast conserving surgery (BCS) and 84 (44%) patients underwent mastectomy. Tumor-positive margins were observed in 67 (35%) patients. Fifty five (51%) had BCS and 12 (14%) underwent mastectomy (p value < 0.001). Re-excision was performed in 35 (33%) patients with BCS and in 4 (5%) patients with mastectomy. Definitive surgery was mastectomy in 107 (56%) patients and BCS in 84 (44%) patients. Tumor-positive margins were associated with cT ≥ 3 status (OR 4.62, 95% CI 1.26-16.98, p value 0.021) in the BCS group. Five-year LRR (4.7%), RFS (81%), and OS (93%) were not affected by type of surgery after NAC.

Conclusion: Although 33% of ILC breast cancer patients undergoing BCS after NAC required re-excision for positive resection margins, it is considered safe given that five-year RFS remained excellent and LRR and OS did not differ by extent of surgery.

Keywords: Breast conserving surgery; Carcinoma; Lobular; Margins of excision; Mastectomy; Neoadjuvant systemic therapy; Overall survival; Recurrence.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. van der Noordaa MEM, Ioan I, Rutgers EJ, van Werkhoven E, Loo CE, Voorthuis R et al (2021) Breast-conserving therapy in patients with cT3 breast cancer with good response to neoadjuvant systemic therapy results in excellent local control: a comprehensive cancer center experience. Ann Surg Oncol 28(12):7383–7394. https://doi.org/10.1245/s10434-021-09865-4 - DOI - PubMed
    1. Spronk PER, Volders JH, van den Tol P, Smorenburg CH, Vrancken PM (2019) Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit. Eur J Surg Oncol 45(2):110–117. https://doi.org/10.1016/j.ejso.2018.09.027 - DOI - PubMed
    1. Shin HC, Han W, Moon HG, Im SA, Moon WK, Park IA et al (2013) Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients. Ann Surg Oncol 20(8):2582–2589. https://doi.org/10.1245/s10434-013-2909-6 - DOI - PubMed
    1. Simons JM, Jacobs JG, Roijers JP, Beek MA, Boonman-de Winter LJM, Rijken AM et al (2021) Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study. Breast Cancer Res Treat 185(2):441–451. https://doi.org/10.1007/s10549-020-05966-y - DOI - PubMed
    1. Mamtani A, King TA (2018) Lobular breast cancer: different disease, different algorithms? Surg Oncol Clin N Am 27(1):81–94. https://doi.org/10.1016/j.soc.2017.07.005 - DOI - PubMed

LinkOut - more resources